ARDX

Ardelyx (ARDX)

About Ardelyx (ARDX)

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Details

Daily high

$6.42

Daily low

$6.08

Price at open

$6.09

52 Week High

$8.40

52 Week Low

$3.49

Market cap

1.5B

Dividend yield

0.00%

Volume

4.9M

Avg. volume

3.3M

P/E ratio

-25.40

Ardelyx News